Detalhe da pesquisa
1.
Baseline Clinical Factors Are Associated With Risk of Complications in Crohn's Disease: Appraisal of the American Gastroenterological Association Clinical Care Pathway.
Am J Gastroenterol
; 119(1): 147-154, 2024 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37713528
2.
Classification and Management of Disorders of the J Pouch.
Am J Gastroenterol
; 118(11): 1931-1939, 2023 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37252759
3.
Interobserver agreement of the modified Paris classification and histology prediction of colorectal lesions in patients with inflammatory bowel disease.
Gastrointest Endosc
; 97(4): 790-798.e2, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36402202
4.
Altered Bile Acid and Pouch Microbiota Composition in Patients With Chronic Pouchitis.
Inflamm Bowel Dis
; 2023 Nov 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38037191
5.
Total Proctocolectomy vs Subtotal/total Colectomy for Neoplasia in Patients With Inflammatory Bowel Disease and Primary Sclerosing Cholangitis.
Inflamm Bowel Dis
; 2023 Dec 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38142126
6.
Novel Therapies for Patients With Inflammatory Bowel Disease.
Gastroenterol Hepatol (N Y)
; 18(8): 453-465, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-36397817
7.
The epidemiology of inflammatory bowel disease in Asia and Asian immigrants to Western countries.
United European Gastroenterol J
; 10(10): 1063-1076, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36479863
8.
Novel Therapies for Managing Cholestasis.
Clin Liver Dis (Hoboken)
; 15(3): 95-99, 2020 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-32257119
9.
Systematic review with meta-analysis: mycophenolate mofetil as a second-line therapy for autoimmune hepatitis.
Aliment Pharmacol Ther
; 49(7): 830-839, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30761563
10.
Hepatic Sarcoidosis: Natural History and Management Implications.
Front Med (Lausanne)
; 6: 232, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31737633
11.
Cholestatic liver diseases: new targets, new therapies.
Therap Adv Gastroenterol
; 11: 1756284818787400, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30159035
12.
Selective cytotoxic and genotoxic activities of 5-(2-bromo-5-methoxybenzylidene)-thiazolidine-2,4-dione against NCI-H292 human lung carcinoma cells.
Pharmacol Rep
; 70(3): 446-454, 2018 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-29627691
13.
Correction to: Selective cytotoxic and genotoxic activities of 5-(2-bromo-5- methoxybenzylidene)-thiazolidine-2,4-dione against NCI-H292 human lung carcinoma cells.
Pharmacol Rep
; 74(5): 1115, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-36109477
14.
Exploring sub-optimal use of an electronic risk assessment tool for venous thromboembolism.
Appl Ergon
; 55: 63-69, 2016 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-26995037
15.
Structure-guided discovery of thiazolidine-2,4-dione derivatives as a novel class of Leishmania major pteridine reductase 1 inhibitors.
Eur J Med Chem
; 123: 639-648, 2016 Nov 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27517809
16.
Synthesis and antimicrobial activities of 5-Arylidene-thiazolidine-2,4-dione derivatives.
Biomed Res Int
; 2014: 316082, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24895565